APA (7th ed.) Citation

Morena, A., Oshima, C., Gebrim, L., Egami, M., Silva, M., Segreto, R., . . . Segreto, H. Early nuclear alterations and immunohistochemical expression of Ki-67, Erb-B2, vascular endothelial growth factor (VEGF), transforming growth factor (TGF-BETA 1) and integrine-linked kinase (ILK) two days after tamoxifen in breast carcinoma.

Chicago Style (17th ed.) Citation

Morena, A.M.L, C.T.F Oshima, L.H Gebrim, M.I Egami, M.R.R Silva, R.A Segreto, O. Giannotti Filho, V.P.C Teixeira, and H.R.C Segreto. Early Nuclear Alterations and Immunohistochemical Expression of Ki-67, Erb-B2, Vascular Endothelial Growth Factor (VEGF), Transforming Growth Factor (TGF-BETA 1) and Integrine-linked Kinase (ILK) Two Days After Tamoxifen in Breast Carcinoma.

MLA (9th ed.) Citation

Morena, A.M.L, et al. Early Nuclear Alterations and Immunohistochemical Expression of Ki-67, Erb-B2, Vascular Endothelial Growth Factor (VEGF), Transforming Growth Factor (TGF-BETA 1) and Integrine-linked Kinase (ILK) Two Days After Tamoxifen in Breast Carcinoma.

Warning: These citations may not always be 100% accurate.